Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. [electronic resource]
Producer: 20151117Description: 1-409, v-vi p. digitalISSN:- 2046-4924
- Antiviral Agents -- economics
- Biomarkers
- Chronic Disease
- Cost-Benefit Analysis
- Diagnostic Techniques and Procedures -- economics
- Elasticity Imaging Techniques
- Hepatitis B, Chronic -- drug therapy
- Hepatitis C, Chronic -- drug therapy
- Humans
- Liver Cirrhosis -- diagnosis
- Liver Diseases -- pathology
- Markov Chains
- Models, Econometric
- Non-alcoholic Fatty Liver Disease -- drug therapy
- Quality-Adjusted Life Years
- Sensitivity and Specificity
- Sex Factors
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.